Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: Risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre

Journal of Hospital Infection

Volumn 58, Issue 1, 2004, Pages 63-77

  Liu, C P ^a,b   Wang, N Y ^a   Lee, C M ^a,c   Weng, L C ^a   Tseng, H K ^a   Liu, C W ^a   Chiang, C S ^a,d   Huang, F Y ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b Mackay Junior School of Nursing   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

Bloodstream infection; Cefepime; Enterobacter cloacae; Resistance; Risk factors; SHV 12; Sulbactam

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; TOBRAMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATE; CENTRAL VENOUS CATHETERIZATION; CHILD; COMMUNICABLE DISEASE; DRUG EFFICACY; ENTEROBACTER CLOACAE; FEMALE; GENE LOCATION; GENOTYPE; GRAM NEGATIVE SEPSIS; HEALTH CENTER; HOSPITAL INFECTION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PLASMID; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; SOUTHERN BLOTTING; TAIWAN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CATHETERIZATION, CENTRAL VENOUS; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RESPIRATION, ARTIFICIAL; RISK FACTORS; SEPSIS; TAIWAN;

EID: 4444345634     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.04.019     Document Type: Article

References (37)

1. Sanders W.E. Jr. Sanders C.C. Enterobacter spp.: pathogens poised to flourish at the turn of the century Clin Microbiol Rev 10 1997 220-241
2. Dijk Y.V. Bik E.M. Hochstenbach-Vernooij S. et al. Management of an outbreak of Enterobacter cloacae in a neonatal unit using simple preventive measures J Hosp Infect 51 2002 21-26
3. Liu S.C. Leu H.S. Yen M.Y. Lee P.I. Chou M.C. Study of an outbreak of Enterobacter cloacae sepsis in a neonatal intensive care unit: the application of epidemiologic chromosome profiling by pulsed-field gel electrophoresis Am J Infect Control 30 2002 381-385
4. Bush K. New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy Clin Infect Dis 32 2001 1085-1089
5. Pitout J.D.D. Sanders C.C. Sanders W.E. Jr. Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli Am J Med 103 1997 51-59
6. Livermore D.M. β-Lactamase-mediated resistance and opportunities for its control J Antimicrob Chemother 41 1998 25-41
7. Knothe H. Shah P. Krcmery V. Antal M. Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens Infection 11 1983 315-317
8. Kliebe C. Nies B.A. Meyer J.F. Tolxdorff-Neutzling R.M. Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins Antimicrob Agents Chemother 28 1985 302-307
9. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933-951
10. Neuwirth C. Siebor E. Lopez J. Pechinot A. Kazmierczak A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum β-lactamase to other members of the family Enterobacteriaceae J Clin Microbiol 34 1996 76-79
11. Pitout J.D.D. Thomson K.S. Hanson N.D. Ehrhardt A.F. Coudron P. Sanders C.C. Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains Antimicrob Agents Chemother 42 1998 596-600
12. Levison M.E. Mailapur Y.V. Pradhan S.K. et al. Regional occurrence of plasmid-mediated SHV-7, an extended-spectrum β-lactamase, in Enterobacter cloacae in Philadelphia teaching hospitals Clin Infect Dis 35 2002 1551-1554
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; 12th informational supplement. NCCLS document, M100-S12. Wayne, PA; 2002
14. Weng L.C. Liaw G.J. Wang N.Y. et al. Investigation of an outbreak of Pseudomonas putida using antimicrobial susceptibility patterns, pulsed-field gel electrophoresis of genomic DNA and restriction fragment length polymorphism of PCR-amplified rRNA operons J Microbiol Immunol Infect 32 1999 187-193
15. Tenover F.C. Arbeit R.D. Goering R.V. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 1995 2233-2239
16. Sinnett D. Richer C. Baccichet A. Isolation of stable bacterial artificial chromosome DNA using a modified alkaline lysis method Biotechniques 24 1998 752-754
17. Rice L.B. Carias L.L. Hujer A.M. et al. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae Antimicrob Agents Chemother 44 2000 362-367
18. Ambler R.P. Coulson A.F.W. Frëre J.M. et al. A standard numbering scheme for the class A β-lactamases Biochem J 276 1991 269-272
19. Nüesch-Inderbinen M.T. Kayser F.H. Hächler H. Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12 Antimicrob Agents Chemother 41 1997 943-949
20. Weischer M. Kolmos H.J. Retrospective 6-year study of enterobacter bacteremia in a Danish university hospital J Hosp Infect 20 1992 15-24
21. al Ansari N. McNamara E.B. Cunney R.J. Flynn M.A. Smyth E.G. Experience with enterobacter bacteraemia in a Dublin teaching hospital J Hosp Infect 27 1994 69-72
22. Pittet D. Li N. Wenzel R.P. Association of secondary and polymicrobial nosocomial bloodstream infections with higher mortality Eur J Clin Microbiol Infect Dis 12 1993 813-819
23. Chow J.W. Fine M.J. Shlaes D.M. et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy Ann Intern Med 115 1991 585-590
24. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases Emerg Infect Dis 7 2001 333-336
25. Livermore D.M. Struelens M. Amorim J. et al. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests J Antimicrob Chemother 49 2002 289-300
26. Yan J.J. Ko W.C. Wu J.J. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-β-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae Antimicrob Agents Chemother 45 2001 2368-7231
27. Kim J. Lee H.J. Rapid discriminatory detection of genes coding for SHV β-lactamases by ligase chain reaction Antimicrob Agents Chemother 44 2000 1860-1864
28. Chanawong A. M'Zali F.H. Heritage J. Lulitanond A. Hawkey P.M. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum β-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand J Antimicrob Chemother 48 2001 839-852
29. Perilli M. Dell'Amico E. Segatore B. et al. Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey J Clin Microbiol 40 2002 611-614
30. Chanawong A. M'Zali F.H. Heritage J. Xiong J.H. Hawkey P.M. Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China Antimicrob Agents Chemother 46 2002 630-637
31. Yan J.J. Wu S.M. Tsai S.H. Wu J.J. Su I.J. Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and identification of a novel AmpC enzyme (CMY-8) in southern Taiwan Antimicrob Agents Chemother 44 2000 1438-1442
32. Chang F.Y. Siu L.K. Fung C.P. Huang M.H. Ho M. Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: gene evolution in northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26 Antimicrob Agents Chemother 45 2001 2407-2413
33. Sanders W.E. Jr. Tenny J.H. Kessler R.E. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species Clin Infect Dis 23 1996 454-461
34. Jones R.N. Biedenbach D.J. Gales A.C. Sustained activity and spectrum of selected extended-spectrum β-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997-2000) Int J Antimicrob Agents 21 2003 1-7
35. Naumiuk L. Samet A. Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method J Antimicrob Chemother 48 2001 321-322
36. Iregui M. Ward S. Sherman G. Fraser V.J. Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia Chest 122 2002 262-268
37. BSAC Disc Diffusion Method for Antimicrobial Susceptibility Testing. Version, 2.1. May; 2003